Acute phase reactants in patients with coronary slow flow phenomenon;Koroner yavaş akım fenomeni olan hastalarda akut faz reaktanları

Anadolu Kardiyoloji Dergisi

Volumn 10, Issue 5, 2010, Pages 416-420

  Madak, Nihat ^a   Nazli, Yunus ^a   Mergen, Haluk ^a   Aysel, Süleyman ^a   Kandaz, Muhammet ^a   Yanik, Ekrem ^b   Çekdemir, Demet ^a   Tavli, Talat ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b Vatan Hospital   (Turkey)

Author keywords

C reactive protein; Coronary angiography; Coronary artery disease; Coronary slow flow; N terminal pro brain natriuretic peptide

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; FIBRINOGEN; LIOTHYRONINE; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLOW RATE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION;

EID: 78049336452     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: 10.5152/akd.2010.139     Document Type: Article

References (25)

1. Goel PK, Gupta SK, Agarwal A, Kapoor A. Slow coronary flow: a distinct angiographic subgroup in syndrome X. Angiology 2001; 52: 507-14.
2. Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E. Angina pectoris and slow flow velocity of dye in coronary arteries. A new angiographic finding. Am Heart J 1972; 84: 66-71.
3. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267: 10931-4.
4. Jang IK, Lassila R, Fuster V. Atherogenesis and inflammation. Eur Heart J 1993; 14 Suppl, K: 2-6.
5. Shah PK, Falk E, Badimon JJ, Fernandez-Ortiz A, Mailhac A, Villareal-Levy G, et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 1995; 92: 1565-9.
6. Ross R. The pathogenesis of atherosclerosis-an update. N Engl J Med 1986; 314: 488-500.
7. Girardi LN, Coselli JS. Inflammatory aneurysm of the ascending aorta and aortic arch. Ann Thorac Surg 1997; 64: 251-3.
8. Miwa K, Igawa A, Inoue H. Soluble E-selectin, ICAM-1 and VCAM-1 levels in systemic and coronary circulation in patients with variant angina. Cardiovasc Res 1997; 36: 37-44.
9. Mosseri M, Yarom R, Gotsman MS, Hasin Y. Histologic evidence for small vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation 1986; 74: 964-72.
10. Sezgin AT, Siǧirci A, Barutçu I, Topal E, Sezgin N, Özdemir R, et al. Vascular endothelial function in patients with slow coronary flow. Coron Artery Dis 2003;14: 155-61.
11. Evrengül H, Tanriverdi H, Enli Y, Kuru O, Seleci D, Baştemir M, et al. Interaction of plasma homocysteine and thyroid hormone concentrations in the pathogenesis of the slow coronary flow phenomenon. Cardiology 2007; 108: 186-92.
12. Li JJ, Fang CH. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular disease. Med Hypotheses 2004; 62: 499-506.
13. Vila G, Resl M, Stelzeneder D, Strucks J, Maier C, Riedl M, et al. Plasma NT-proBNP increases in response to LPS administration in healthy men. J Appl Physiol 2008;105: 1741-5.
14. Gibson CM, Cannon CP, Daley WL, Dodge JT, Alexander B, Marble SJ, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996; 93: 879-88.
15. Dodge JT, Brown BG, Bolson EL, Dodge HT. Intrathoracic spatial location of specified coronary segments on the normal human heart: application in quantitative arteriography, assessment of regional risk and contraction, and anatomic display. Circulation 1988; 78: 1167-80.
16. Li JJ, Qin XW, Li ZC, Zeng HS, Gao Z, Xu B, et al. Increased plasma C-reactive protein and interleukin-6 concentrations in patients with slow coronary flow. Clin Chim Acta 2007; 385: 43-7.
17. Yazici M, Aksakal E, Demircan S, Şahin M, Saǧkan O. Is slow coronary flow related with inflammation and procoagulant state? Anadolu Kardiyol Derg 2005; 5: 3-7.
18. Pekdemir H, Cin VG, Çiçek D, Çamsari A, Akkuş N, Döven O, et al. Slow coronary flow may be a sign of diffuse atherosclerosis: contribution of FFR and IVUS. Acta Cardiol 2004; 59: 127-33.
19. Slevin M, Krupinski J. A role of C-reactive protein in the regulation of angiogenesis, endothelial cell inflammation and thrombus formation in cardiovascular disease. Histol Histopathol 2009; 24: 1473-8.
20. Sullivan GW, Sarembock IJ, Linden J. The role of inflammation in vascular disease. J Leukoc Biol 2000; 67: 591-602.
21. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323: 27-36.
22. De Meyer GR, Herman AG. Vascular endothelial dysfunction. Prog Cardiovasc Dis 1997; 39: 325-42.
23. Turhan H, Saydam GS, Erbay AR, Ayaz S, Yaşar AS, Aksoy Y, et al. Increased plasma soluble adhesion molecules: ICAM-1, VCAM-1, and E-selectin concentrations in patients with slow coronary flow. Int J Cardiol 2006; 108: 224-30.
24. Baykan M, Baykan EC, Turan S, Gedikli O, Kaplan S, Kiriş A, et al. Assessment of left ventricular function and Tei index by tissue Doppler imaging in patients with slow coronary flow. Echocardiography 2009: 26; 1167-72.
25. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: The Rotterdam Study. Ann Intern Med 2000; 132: 270-8.